Johns Hopkins will launch an institute devoted to the study of a new
and promising approach to cancer treatment, embracing the Obama
administration's "moonshot" initiative to cure cancer, an effort led by
Vice President Joe Biden.
The Bloomberg, Kimmel Institute for Cancer Immunotherapy was founded
with two $50 million gifts, one from Michael R. Bloomberg,
philanthropist, entrepreneur, and three-term mayor of New York City; the
other from philanthropist Sidney Kimmel, founder of Jones Apparel
Group. An additional $25 million for the center was contributed by more
than a dozen additional supporters.
Immunotherapy has the potential to cure and end all forms of cancer,
researchers say, making it the most rapidly advancing approach to cancer
treatment and one of the most promising avenues of cancer research
today. Immunotherapy seeks to redirect patients' highly individual
immune systems to target, detect, and destroy cancer cells.
"We are at the forefront of an emerging and promising field of cancer
research and treatment," said Paul Rothman, dean and CEO of Johns
Hopkins Medicine. "We are grateful for these tremendous gifts, which
will help us accelerate the already rapid pace of discoveries in
immunotherapy."
No comments:
Post a Comment